288 filings
Page 2 of 15
8-K
waclzfwq9iow8jik
14 Feb 24
Other Events
4:11pm
424B5
jjvqm
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
6e57z
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
5m9lrr
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
4d5e90kd7odagh
13 Feb 24
Automatic shelf registration
4:04pm
SC 13G/A
0yriz3t jfil73zcuv0
12 Feb 24
Immunome / Alpine Global Management ownership change
2:10pm
SC 13G
yk4mm6z
9 Feb 24
Immunome / FMR ownership change
9:16am
8-K
69085
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
S-8
lk97bk7 pn5ymjlgcu7
2 Feb 24
Registration of securities for employees
4:04pm
8-K
9doohcvm8xg vwnj
31 Jan 24
Departure of Directors or Certain Officers
9:18pm
4
sodm42m2ayw3mc3fu
31 Jan 24
Immunome / Max Rosett ownership change
8:53pm
4
tyqqr8gaq3mox a24wj
31 Jan 24
Immunome / Sandra G. Stoneman ownership change
8:50pm
8-K
f63adyi3f97vsw 4girc
11 Jan 24
Regulation FD Disclosure
5:27pm
8-K
suucfu5isht1qsj8jv2
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
3
ybhl6vw84x5 q2wt
4 Jan 24
Immunome / Bob Lapetina ownership change
5:40pm
4
pe0vgv 7f9nf9kxj4ipq
4 Jan 24
Immunome / CAROL SCHAFER ownership change
5:37pm
3
3q5gc
4 Jan 24
Immunome / CAROL SCHAFER ownership change
5:33pm
8-K
mu0wy9d
2 Jan 24
Departure of Directors or Certain Officers
8:05am
8-K
ykgnv9izx19pr
29 Dec 23
Departure of Directors or Certain Officers
5:00pm
8-K
vc9b2
26 Dec 23
Other Events
8:35am